No. |
Product Name |
CAS No. |
Spec |
Price |
|
| A-2148 |
PF 04447943(PF 4447943), 99.8% |
1082744-20-4 |
|
|
| A-2020 |
PF 4693627(PF 04693627), 100%|>98%d.e |
1312815-93-2 |
|
|
| A-2295 |
PPQ 102, 99.8% |
931706-15-9 |
|
|
| A-2299 |
Remodelin, 99.2% |
949912-58-7 |
|
|
| A-2352 |
Roflumilast(Daxas), 100% |
162401-32-3 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2370 |
SB-3CT, 99.1% |
292605-14-2 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-1799 |
SSR 125543A(SSR 125543 HCl), 98.7% |
321839-75-2 |
|
|
| A-2314 |
Stattic, 99.8% |
19983-44-9 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2128 |
Stem Cell 2i inhibitor Set, >99%(PD 0325901+CHIR 99021) |
391210-10-9+252917-06-9 |
| 2+2mg |
Inquiry |
| 5+5mg |
Inquiry |
|
|
| A-2129 |
Stem Cell 3i inhibitor Set, >99%(SU 5402+PD 184352+CHIR 99021) |
215543-92-3+212631-79-3+252917-06-9 |
| 3*2mg |
Inquiry |
| 3*5mg |
Inquiry |
|
|
| A-2130 |
Stem Cell Alternative 2i inhibitor Set, >99%(CGP 77675+CHIR 99021) |
234772-64-6+252917-06-9 |
| 2+2mg |
Inquiry |
| 5+5mg |
Inquiry |
|
|
| A-2124 |
TAK 700(Orteronel), 99.8% |
566939-85-3 |
|
|
| A-2326 |
Temozolomide(TMZ|NSC 362856),100% |
85622-93-1 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2272 |
TH 588 HCl, 99.4% |
1609960-31-7 net |
|
|
| A-2344 |
TM 5275, 99.9% |
1103926-82-4 |
|
|
| A-2346 |
UNC 2250, 99.6% |
1493694-70-4 |
|
|
| A-2369 |
UPF 1069, 99.3% |
1048371-03-4 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| A-2287 |
Wnt-C59(C59), 98.9% |
1243243-89-1 |
|
|
| A-2316 |
WP 1066, 99.7% |
857064-38-1 |
| 10mg |
Inquiry |
| 50mg |
Inquiry |
|
|
| CM-05056 |
Eicosapentaenoic Acid-d5 ≥99% |
1197205-73-4 |
|
|
